| Autor: |
Andinet, Gizaw, Wendy C, King, Amanda S, Hinerman, Raymond T, Chung, Mauricio, Lisker-Melman, Marc G, Ghany, Mandana, Khalili, Mamta K, Jain, Jacob, Graham, Theresa, Swift-Scanlan, David E, Kleiner, Mark, Sulkowski, David K, Wong, Richard K, Sterling |
| Rok vydání: |
2021 |
| Zdroj: |
HIV medicine. |
| ISSN: |
1468-1293 |
| Popis: |
Tenofovir disoproxil fumarate (TDF) is a common component of antiretroviral therapy in hepatitis B virus (HBV)-HIV co-infected adults but few studies have evaluated worsening renal function and bone turnover, known effects of TDF.Adults from eight North American sites were enrolled in this cohort study. Research assessments were conducted at entry and every 24 weeks for ≤192 weeks. Bone markers were tested at baseline, week 96 and week 192 from stored serum. We evaluated changes in markers of renal function and bone turnover over time and potential contributing factors.A total of 115 patients were prospectively followed; median age 49 years, 91% male and 52% non-Hispanic Black. Duration of HIV was 20.5 years. TDF use ranged from 80% to 92% throughout follow-up. Estimated glomerular filtration rate (eGFR) (ml/min/1.73mIn this HBV-HIV cohort with high prevalence of TDF use, several biomarkers of renal function and bone turnover indicated worsening status over approximately 4 years, highlighting the importance of clinical awareness in co-infected adults. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Plný text